Relative resistance to nasally induced tolerance in non-obese diabetic mice but not other I-Ag7-expressing mouse strains

International Immunology

Volumn 13, Issue 10, 2001, Pages 1321-1333

  Quinn, Anthony ^a   Melo, Marco ^c,d   Ethell, Douglas ^b   Sercarz, Eli E ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b Division of Cellular Immunology   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HOLLAND LABORATORY   (United States)

Author keywords

Apoptosis; Hen egg lysozyme; Immune deviation; Mucosal; T cells

Indexed keywords

ANTIGEN; CD3 ANTIGEN; CYTOKINE; IA ANTIGEN; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CELL DEATH; COMPARATIVE STUDY; CONGENIC STRAIN; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; FEMALE; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MOUSE; MOUSE STRAIN; NONHUMAN; NOSE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RECALL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0034776836     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/13.10.1321     Document Type: Article

References (58)

1. Insulin-dependent diabetes mellitus: The initial lesion
2. Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjogren's syndrome
3. Breaking self-tolerance in nonobese diabetic mice
4. g7 molecules from non-obese diabetic mice are poor peptide binders
5. Positive selection of lymphocytes
6. Negative selection of lymphocytes
7. The NOD mouse: Recessive diabetogenic gene in the major histocompatibility complex
8. The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique
9. Genetic control of autoimmune diabetes in the NOD mouse
10. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus
11. g7 beta chain in peptide binding and antigen recognition by T cells
12. g7-dependent reaction
13. Suppression of the immune response by nasal immunization
14. Suppression of murine collagen-induced arthritis by nasal administration of collagen
15. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: Influence of MHC binding affinity
16. Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay
17. Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death
18. A role for perforin in activation-induced cell death
19. A role for perforin in activation-induced T cell death in vivo: Increased expansion of allogeneic perforin-deficient T cells in SCID mice
20. h-2 responses and exacerbation of disease
21. Crosses of NOD mice with the related NON strain. A polygenic model for IDDM
22. The murine autoimmune diabetes model: NOD and related strains
23. NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice
24. Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen
25. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo
26. Two CD95 (APO-1/Fas) signaling pathways
27. The role of c-FLIP in modulation of CD95-induced apoptosis
28. BCL-2 family members and the mitochondria in apoptosis
29. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes
30. A peptide-binding motif for I-A (g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice
31. h1 cells induce diabetes in NOD/SCID mice
32. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens
33. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases
34. Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells
35. h1 cells
36. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans
37. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease
38. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection
39. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice
40. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes
41. + lymphocytes in autoimmune disease. Studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice
42. + T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors
43. h2 responses and prevents murine insulin-dependent diabetes
44. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)
45. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes
46. h2) responses to pancreatic islet autoantigens
47. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice
48. Genetic analysis of immune dysfunction in non-obese diabetic (NOD) mice: Mapping of a susceptibility locus close to the Bcl-2 gene correlates with increased resistance of NOD T cells to apoptosis induction
49. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region
50. Sex difference in resistance to dexamethasone-induced apoptosis in NOD mice: Treatment with 1,25 (OH)2D3 restores defect
51. Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x
52. Programmed cell death in the pathogenesis of murine IDDM: Resistance to apoptosis induced in lymphocytes by cyclophosphamide
53. Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene
54. Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies
55. Exogenous administration of IL-1 alpha inhibits active and adoptive transfer autoimmune diabetes in NOD mice
56. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity
57. Splenic macrophages from the NOD mouse are defective in the ability to present antigen
58. Cutting edge: Homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice